Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2009

01.12.2009 | Case Report

Bilateral pheochromocytoma during the postpartum period

verfasst von: Lalita Wattanachanya, Udomsak Bunworasate, Wanee Plengpanich, Natnicha Houngngam, Patinut Buranasupkajorn, Sarat Sunthornyothin, Vorasuk Shotelersuk, Thiti Snabboon

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Pheochromocytoma manifesting during pregnancy is uncommon but it is responsible for a high maternal and fetal mortality rate, especially when unrecognized. Most cases of pheochromocytoma are sporadic but they can be part of hereditary autosomal dominant syndromes.

Case

We describe a case of bilateral pheochromocytoma in a term-pregnant patient with a previous history of medullary thyroid carcinoma (MTC). Her genetic study revealed a heterozygous mutation, c.1900T>C, in the RET proto-oncogene which confirmed the diagnosis of multiple endocrine neoplasia type 2A (MEN2A). Unrecognized, the tumors caused a crisis with fatal outcome in the mother during the postpartum period. This event might have been prevented if the tumor had been detected previously.

Conclusion

MEN2A affected pregnancy is an unusual condition. This syndrome should be suspected when a pregnant patient has a history of MTC. Early detection and appropriate management can prevent serious maternal and fetal complications. We also reviewed the literature of MEN2A-affected pregnancies.
Literatur
2.
Zurück zum Zitat Phupong V, Witoonpanich P, Snabboon T, Tharavej C, Ultchaswadi P (2005) Bilateral pheochromocytoma during pregnancy. Arch Gynecol Obstet 271:276–279PubMed Phupong V, Witoonpanich P, Snabboon T, Tharavej C, Ultchaswadi P (2005) Bilateral pheochromocytoma during pregnancy. Arch Gynecol Obstet 271:276–279PubMed
3.
Zurück zum Zitat Mannelli M, Bemporad D (2002) Diagnosis and management of pheochromocytoma during pregnancy. J Endocrinol Invest 25:567–571PubMed Mannelli M, Bemporad D (2002) Diagnosis and management of pheochromocytoma during pregnancy. J Endocrinol Invest 25:567–571PubMed
4.
Zurück zum Zitat Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671. doi:10.1210/jc.86.12.5658 CrossRefPubMed Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671. doi:10.​1210/​jc.​86.​12.​5658 CrossRefPubMed
5.
Zurück zum Zitat Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA Jr (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851–856. doi:10.1093/hmg/2.7.851 CrossRefPubMed Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA Jr (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851–856. doi:10.​1093/​hmg/​2.​7.​851 CrossRefPubMed
6.
Zurück zum Zitat Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H, European Multiple Endocrine Neoplasia (EUROMEN) Study Group (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517–1525. doi:10.1056/NEJMoa012915 CrossRefPubMed Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H, European Multiple Endocrine Neoplasia (EUROMEN) Study Group (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517–1525. doi:10.​1056/​NEJMoa012915 CrossRefPubMed
7.
Zurück zum Zitat Kim J, Reutrakul S, Davis DB, Kaplan EL, Refetoff S (2004) Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess. Eur J Endocrinol 151:771–777. doi:10.1530/eje.0.1510771 CrossRefPubMed Kim J, Reutrakul S, Davis DB, Kaplan EL, Refetoff S (2004) Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess. Eur J Endocrinol 151:771–777. doi:10.​1530/​eje.​0.​1510771 CrossRefPubMed
8.
Zurück zum Zitat Moran ME, Rosenberg DJ, Zornow DH (2006) Pheochromocytoma multisystem crisis. Urology 67:846e19–846e20CrossRef Moran ME, Rosenberg DJ, Zornow DH (2006) Pheochromocytoma multisystem crisis. Urology 67:846e19–846e20CrossRef
10.
Zurück zum Zitat Moraca-Kvapilová L, Op de Coul AA, Merkus JM (1985) Cerebral haemorrhage in a pregnant woman with a multiple endocrine neoplasia syndrome (type 2A or Sipple’s syndrome). Eur J Obstet Gynecol Reprod Biol 20:257–263CrossRefPubMed Moraca-Kvapilová L, Op de Coul AA, Merkus JM (1985) Cerebral haemorrhage in a pregnant woman with a multiple endocrine neoplasia syndrome (type 2A or Sipple’s syndrome). Eur J Obstet Gynecol Reprod Biol 20:257–263CrossRefPubMed
11.
Zurück zum Zitat van der Vaart CH, Heringa MP, Dullaart RP, Aarnoudse JG (1993) Multiple endocrine neoplasia presenting as phaeochromocytoma during pregnancy. Br J Obstet Gynaecol 100:1144–1145PubMed van der Vaart CH, Heringa MP, Dullaart RP, Aarnoudse JG (1993) Multiple endocrine neoplasia presenting as phaeochromocytoma during pregnancy. Br J Obstet Gynaecol 100:1144–1145PubMed
13.
Zurück zum Zitat Huang SM, Tao BL, Tzeng CC, Liu HT, Wang WP (1997) Prenatal molecular diagnosis of RET proto-oncogene mutation in multiple endocrine neoplasia type 2A. J Formos Med Assoc 96:542–544PubMed Huang SM, Tao BL, Tzeng CC, Liu HT, Wang WP (1997) Prenatal molecular diagnosis of RET proto-oncogene mutation in multiple endocrine neoplasia type 2A. J Formos Med Assoc 96:542–544PubMed
15.
Zurück zum Zitat Tewari KS, Steiger RM, Lam ML, Rutgers JK, Berkson RA, DiSaia PJ (2001) Bilateral pheochromocytoma in pregnancy heralding multiple endocrine neoplasia syndrome IIA. A case report. J Reprod Med 46:385–388PubMed Tewari KS, Steiger RM, Lam ML, Rutgers JK, Berkson RA, DiSaia PJ (2001) Bilateral pheochromocytoma in pregnancy heralding multiple endocrine neoplasia syndrome IIA. A case report. J Reprod Med 46:385–388PubMed
16.
Zurück zum Zitat Martínez Brocca MA, Acosta Delgado D, Quijada D, Navarro González E, Soto Moreno A, Gonzáles Duarte D, del Valle López de Ayala A, Astorga Jiménez R (2001) Pheochromocytoma in a pregnant woman with multiple endocrine neoplasia type 2a. Gynecol Endocrinol 15:439–442CrossRefPubMed Martínez Brocca MA, Acosta Delgado D, Quijada D, Navarro González E, Soto Moreno A, Gonzáles Duarte D, del Valle López de Ayala A, Astorga Jiménez R (2001) Pheochromocytoma in a pregnant woman with multiple endocrine neoplasia type 2a. Gynecol Endocrinol 15:439–442CrossRefPubMed
18.
Zurück zum Zitat Martinelli P, Maruotti GM, Pasquali D, Paladini D, Agangi A, Rippa E, Colantuoni V, Bellastella A, Sinisi AA (2004) Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): a case report. J Endocrinol Invest 27:357–360PubMed Martinelli P, Maruotti GM, Pasquali D, Paladini D, Agangi A, Rippa E, Colantuoni V, Bellastella A, Sinisi AA (2004) Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): a case report. J Endocrinol Invest 27:357–360PubMed
19.
Zurück zum Zitat Langerman A, Schneider JA, Ward RP (2004) Pheochromocytoma storm presenting as cardiovascular collapse at term pregnancy. Rev Cardiovasc Med 5:226–230PubMed Langerman A, Schneider JA, Ward RP (2004) Pheochromocytoma storm presenting as cardiovascular collapse at term pregnancy. Rev Cardiovasc Med 5:226–230PubMed
20.
Zurück zum Zitat Frayssinet C, Vezzosi D, Huyghe E, Lorenzini F, Bennet A, Caron P (2008) Retroperitoneal laparoscopic adrenalectomy in a pregnant woman presenting MEN2a with a pheochromocytoma: case report and review of the literature. Ann Endocrinol (Paris) 69:53–57. doi:10.1016/j.ando.2007.10.005 Frayssinet C, Vezzosi D, Huyghe E, Lorenzini F, Bennet A, Caron P (2008) Retroperitoneal laparoscopic adrenalectomy in a pregnant woman presenting MEN2a with a pheochromocytoma: case report and review of the literature. Ann Endocrinol (Paris) 69:53–57. doi:10.​1016/​j.​ando.​2007.​10.​005
Metadaten
Titel
Bilateral pheochromocytoma during the postpartum period
verfasst von
Lalita Wattanachanya
Udomsak Bunworasate
Wanee Plengpanich
Natnicha Houngngam
Patinut Buranasupkajorn
Sarat Sunthornyothin
Vorasuk Shotelersuk
Thiti Snabboon
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2009
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-009-1057-5

Weitere Artikel der Ausgabe 6/2009

Archives of Gynecology and Obstetrics 6/2009 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.